NERIVIONOW Trademark

Trademark Overview

On Wednesday, April 17, 2024, a trademark application was filed for NERIVIONOW with the United States Patent and Trademark Office. The USPTO has given the NERIVIONOW trademark a serial number of 98504688. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 17, 2024. This trademark is owned by THERANICA BIO-ELECTRONICS LTD.. The NERIVIONOW trademark is filed in the Medical Instrument Products category with the following description:

Medical devices employing a neuromodulator, namely, a non-invasive electronic neuromodulator device for medical use enabling the acute treatment of migraines, fibromyalgia, irritable bowel syndrome and other diseases characterized with idiopathic pain.
nerivionow

General Information

Serial Number98504688
Word MarkNERIVIONOW
Filing DateWednesday, April 17, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, October 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2024

Trademark Statements

Pseudo MarkNERIVIONOW
Goods and ServicesMedical devices employing a neuromodulator, namely, a non-invasive electronic neuromodulator device for medical use enabling the acute treatment of migraines, fibromyalgia, irritable bowel syndrome and other diseases characterized with idiopathic pain.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, April 17, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTHERANICA BIO-ELECTRONICS LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNetanya 4250438
IL

Trademark Events

Event DateEvent Description
Wednesday, April 17, 2024NEW APPLICATION ENTERED
Wednesday, October 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 9, 2024ASSIGNED TO EXAMINER
Thursday, October 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

nerivionow neuromodulator medical bowel syndrome irritable other diseases pain idiopathic characterized